Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risankizumab in Children With Crohn's Disease (RisaKids): A Multi-center PORTO Group Prospective Study

NCT06298188 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.

NCT NCT06298188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06298188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risankizumab in Children With Crohn's Disease (RisaKids): A Multi-center PORTO Group Prospective Study
Lead sponsor
Shaare Zedek Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2024
Completion date
October 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease